Home > Financial Ratios > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results

SUVEN PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) -27.84-15.3241.0512.11166.14

What is the latest EBIT Growth ratio of SUVEN PHARMACEUTICALS ?

The latest EBIT Growth ratio of SUVEN PHARMACEUTICALS is -27.84 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar2024-27.84
Mar2023-15.32
Mar202241.05
Mar202112.11
Mar2020166.14

How is EBIT Growth of SUVEN PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2024 -27.84
Negative
Mar2023 -15.32
Negative
Mar2022 41.05
238.98
Mar2021 12.11
-92.71
Mar2020 166.14 -

Other Financial Ratios of SUVEN PHARMACEUTICALS


Compare EBIT Growth ratio of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹29,733.5 Cr 10.7% 3.4% 92.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 0.2% 1% 6.3% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 6.8% 1.6% 53.3% Stock Analytics
CIPLA ₹122,390.0 Cr 4.4% 2.9% 4.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr -0.7% 4% 25.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 4.6% 4.9% -6.2% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

10.7%

3.4%

92.3%

SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses